Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001168404-22-000003
Filing Date
2022-11-29
Accepted
2022-11-28 19:17:05
Documents
1
Effectiveness Date
2022-11-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12775
  Complete submission text file 0001168404-22-000003.txt   14130
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-465960 | Film No.: 221427815
SIC: 2835 In Vitro & In Vivo Diagnostic Substances